Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does POTASSIUM PERCHLORATE Cause Activated partial thromboplastin time prolonged? 17 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Activated partial thromboplastin time prolonged have been filed in association with POTASSIUM PERCHLORATE. This represents 34.7% of all adverse event reports for POTASSIUM PERCHLORATE.

17
Reports of Activated partial thromboplastin time prolonged with POTASSIUM PERCHLORATE
34.7%
of all POTASSIUM PERCHLORATE reports
17
Deaths
15
Hospitalizations

How Dangerous Is Activated partial thromboplastin time prolonged From POTASSIUM PERCHLORATE?

Of the 17 reports, 17 (100.0%) resulted in death, 15 (88.2%) required hospitalization, and 15 (88.2%) were considered life-threatening.

Is Activated partial thromboplastin time prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for POTASSIUM PERCHLORATE. However, 17 reports have been filed with the FAERS database.

What Other Side Effects Does POTASSIUM PERCHLORATE Cause?

Condition aggravated (28) Off label use (28) Myasthenia gravis (25) Somnolence (25) Multiple organ dysfunction syndrome (24) Sepsis (24) Stress (24) Drug hypersensitivity (23) General physical health deterioration (23) Hyponatraemia (23)

What Other Drugs Cause Activated partial thromboplastin time prolonged?

DABIGATRAN ETEXILATE (264) HEPARIN (225) RIVAROXABAN (163) WARFARIN (146) ACETAMINOPHEN (119) ALLOPURINOL (110) AMIODARONE (99) METRONIDAZOLE (98) SIMVASTATIN (94) DARBEPOETIN ALFA (93)

Related Pages

POTASSIUM PERCHLORATE Full Profile All Activated partial thromboplastin time prolonged Reports All Drugs Causing Activated partial thromboplastin time prolonged POTASSIUM PERCHLORATE Demographics